-
1
-
-
65849407900
-
Hypertension and diabetes: A toxic combination
-
Bell DS: Hypertension and diabetes: a toxic combination. Endocr Pract 2008; 14: 1031-1039.
-
(2008)
Endocr Pract
, vol.14
, pp. 1031-1039
-
-
Bell, D.S.1
-
2
-
-
2642575030
-
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists
-
DOI 10.1161/01.CIR.0000131449.94713.AD
-
Azizi M, Ménard J: Combined blockade of the renin-angiotensin system with angiotensin- converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Circulation 2004; 109: 2492-2499. (Pubitemid 38720545)
-
(2004)
Circulation
, vol.109
, Issue.21
, pp. 2492-2499
-
-
Azizi, M.1
Menard, J.2
-
3
-
-
36749043046
-
Effects of renin-angiotensin system inhibition end-organ protection: Can we do better?
-
DOI 10.1016/j.clinthera.2007.09.019, PII S0149291807003001
-
Weir MR: Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Clin Ther 2007; 29: 1803-1824. (Pubitemid 350214460)
-
(2007)
Clinical Therapeutics
, vol.29
, Issue.9
, pp. 1803-1824
-
-
Weir, M.R.1
-
4
-
-
30944451141
-
Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension
-
DOI 10.1016/j.diabres.2005.06.010, PII S0168822705002792
-
Sengul AM, Altuntas Y, Kürklü A, Aydin L: Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension. Diabetes Res Clin Pract 2006; 71: 210-219. (Pubitemid 43112114)
-
(2006)
Diabetes Research and Clinical Practice
, vol.71
, Issue.2
, pp. 210-219
-
-
Sengul, A.M.1
Altuntas, Y.2
Kurklu, A.3
Aydin, L.4
-
5
-
-
25444533272
-
Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension
-
DOI 10.1007/s00228-005-0931-8
-
Anan F, Takahashi N, Ooie T, Yufu K, Hara M, Nakagawa M, Yonemochi H, Saikawa T, Yoshimatsu H: Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension. Eur J Clin Pharmacol 2005; 61: 353-359. (Pubitemid 41569309)
-
(2005)
European Journal of Clinical Pharmacology
, vol.61
, Issue.5-6
, pp. 353-359
-
-
Anan, F.1
Takahashi, N.2
Ooie, T.3
Yufu, K.4
Hara, M.5
Nakagawa, M.6
Yonemochi, H.7
Saikawa, T.8
Yoshimatsu, H.9
-
6
-
-
42049107348
-
Telmisartan, ramipril, or both in patients at high risk for vascular events
-
DOI 10.1056/NEJMoa0801317
-
ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C: Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559. (Pubitemid 351522739)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.15
, pp. 1547-1559
-
-
Yusuf, S.1
Teo, K.K.2
Pogue, J.3
Dyal, L.4
Copland, I.5
Schumacher, H.6
Dagenais, G.7
Sleight, P.8
Anderson, C.9
-
7
-
-
49149087718
-
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial
-
ONTARGET Investigators
-
Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S, ONTARGET Investigators: Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008; 372: 547-553.
-
(2008)
Lancet
, vol.372
, pp. 547-553
-
-
Mann, J.F.1
Schmieder, R.E.2
McQueen, M.3
Dyal, L.4
Schumacher, H.5
Pogue, J.6
Wang, X.7
Maggioni, A.8
Budaj, A.9
Chaithiraphan, S.10
Dickstein, K.11
Keltai, M.12
Metsärinne, K.13
Oto, A.14
Parkhomenko, A.15
Piegas, L.S.16
Svendsen, T.L.17
Teo, K.K.18
Yusuf, S.19
-
8
-
-
46249110505
-
Endogenous digitalis: Pathophysiologic roles and therapeutic applications
-
DOI 10.1038/ncpneph0848, PII NCPNEPH0848
-
Bagrov AY, Shapiro JI. Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat Clin Pract Nephrol 2008; 4: 378-392. (Pubitemid 351913708)
-
(2008)
Nature Clinical Practice Nephrology
, vol.4
, Issue.7
, pp. 378-392
-
-
Bagrov, A.Y.1
Shapiro, J.I.2
-
9
-
-
15944419583
-
N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
-
DOI 10.1001/jama.293.13.1609
-
Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P: N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005; 293: 1609-1616. (Pubitemid 40471791)
-
(2005)
Journal of the American Medical Association
, vol.293
, Issue.13
, pp. 1609-1616
-
-
Kistorp, C.1
Raymond, I.2
Pedersen, F.3
Gustafsson, F.4
Faber, J.5
Hildebrandt, P.6
-
10
-
-
44249117135
-
Microalbuminuria in systolic and diastolic chronic heart failure patients
-
Orea-Tejeda A, Colín-Ramírez E, Hernández- Gilsoul T, Castillo-Martínez L, Abasta- Jiménez M, Asensio-Lafuente E, Narváez David R, Dorantes-García J: Microalbuminuria in systolic and diastolic chronic heart failure patients. Cardiol J 2008; 15: 143-149. (Pubitemid 351721975)
-
(2008)
Cardiology Journal
, vol.15
, Issue.2
, pp. 143-149
-
-
Orea-Tejeda, A.1
Colin-Ramirez, E.2
Hernandez-Gilsoul, T.3
Castillo-Martinez, L.4
Abasta-Jimenez, M.5
Asensio-Lafuente, E.6
David, R.N.7
Dorantes-Garcia, J.8
-
11
-
-
33645231864
-
Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: Immunonephelometry compared with high-performance liquid chromatography
-
Polkinghorne KR, Su Q, Chadban SJ, Shaw JE, Zimmet PZ, Atkins RC: Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography. Am J Kidney Dis 2006; 47: 604-613.
-
(2006)
Am J Kidney Dis
, vol.47
, pp. 604-613
-
-
Polkinghorne, K.R.1
Su, Q.2
Chadban, S.J.3
Shaw, J.E.4
Zimmet, P.Z.5
Atkins, R.C.6
-
12
-
-
0033012555
-
Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: Five-year follow-up of the hoorn study
-
Jager A, Kostense PJ, Ruhé HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CD: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: fiveyear follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624. (Pubitemid 29135163)
-
(1999)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.19
, Issue.3
, pp. 617-624
-
-
Jager, A.1
Kostense, P.J.2
Ruhe, H.G.3
Heine, R.J.4
Nijpels, G.5
Dekker, J.M.6
Bouter, L.M.7
Stehouwer, C.D.A.8
-
13
-
-
0026745021
-
Microalbuminuria. Implications for micro- and macro-vascular disease
-
Deckert T, Kofoed-Enevoldsen A, Nørgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T: Microalbuminuria. Implications for micro- and macro-vascular disease. Diabetes Care 1992; 15: 1181-1191.
-
(1992)
Diabetes Care
, vol.15
, pp. 1181-1191
-
-
Deckert, T.1
Kofoed-Enevoldsen, A.2
Nørgaard, K.3
Borch-Johnsen, K.4
Feldt-Rasmussen, B.5
Jensen, T.6
-
14
-
-
0030720863
-
Prevalence and clinical correlates of microalbuminuria in essential hypertension: The MAGIC study
-
Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, Ruello N, Tomolillo C, Castello C, Grillo G, Sacchi G, Deferrari G: Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC study. A Genoa investigation on complications. Hypertension 1997; 30: 1135-1143. (Pubitemid 27476170)
-
(1997)
Hypertension
, vol.30
, Issue.5
, pp. 1135-1143
-
-
Pontremoli, R.1
Sofia, A.2
Ravera, M.3
Nicolella, C.4
Viazzi, F.5
Tirotta, A.6
Ruello, N.7
Tomolillo, C.8
Castello, C.9
Grillo, G.10
Sacchi, G.11
Deferrari, G.12
-
15
-
-
9244223620
-
Characterization of immunochemically nonreactive urinary albumin
-
DOI 10.1373/clinchem.2004.039743
-
Osicka TM, Comper WD: Characterization of immunochemically nonreactive urinary albumin. Clin Chem 2004; 50: 2286-2291. (Pubitemid 39552163)
-
(2004)
Clinical Chemistry
, vol.50
, Issue.12
, pp. 2286-2291
-
-
Osicka, T.M.1
Comper, W.D.2
-
16
-
-
32844462029
-
The analysis and characterisation of immuno-unreactive urinary albumin in healthy volunteers
-
DOI 10.1016/j.clinbiochem.2005.10.013, PII S0009912005002821
-
Clavant SP, Sastra SA, Osicka TM, Comper WD: The analysis of immuno-unreactive urinary albumin in healthy volunteers. Clin Biochem 2006; 39: 143-151. (Pubitemid 43255503)
-
(2006)
Clinical Biochemistry
, vol.39
, Issue.2
, pp. 143-151
-
-
Clavant, S.P.1
Sastra, S.A.2
Osicka, T.M.3
Comper, W.D.4
-
17
-
-
34748862301
-
Microalbuminuria and cardiovascular disease
-
Weir MR: Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007; 2: 581-590.
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, pp. 581-590
-
-
Weir, M.R.1
-
18
-
-
0035152430
-
Radioiodinated tyrosyl-ouabain and measurement of a circulating ouabain-like compound
-
Vakkuri O, Arnason SS, Joensuu P, Jalonen J, Vuolteenaho O, Leppäluoto J: Radioiodinated tyrosyl-ouabain and measurement of a circulating ouabain-like compound. Clin Chem 2001; 47: 95-101. (Pubitemid 32064281)
-
(2001)
Clinical Chemistry
, vol.47
, Issue.1
, pp. 95-101
-
-
Vakkuri, O.1
Arnason, S.S.2
Joensuu, P.3
Jalonen, J.4
Vuolteenaho, O.5
Leppaluoto, J.6
-
19
-
-
1342312361
-
Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys™ 1010 and 2010 analysers
-
DOI 10.1016/j.ejheart.2004.01.011
-
Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R: Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 2004; 6: 365-368. (Pubitemid 38253059)
-
(2004)
European Journal of Heart Failure
, vol.6
, Issue.3
, pp. 365-368
-
-
Collinson, P.O.1
Barnes, S.C.2
Gaze, D.C.3
Galasko, G.4
Lahiri, A.5
Senior, R.6
-
20
-
-
4644335341
-
American Society of Echocardiography: American Society of Echocardiography recommendations for use of echocardiography in clinical trials
-
Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, Morehead A, Kitzman D, Oh J, Quinones M, Schiller NB, Stein JH, Weissman NJ, American Society of Echocardiography: American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004; 17: 1086-1119.
-
(2004)
J Am Soc Echocardiogr
, vol.17
, pp. 1086-1119
-
-
Gottdiener, J.S.1
Bednarz, J.2
Devereux, R.3
Gardin, J.4
Klein, A.5
Manning, W.J.6
Morehead, A.7
Kitzman, D.8
Oh, J.9
Quinones, M.10
Schiller, N.B.11
Stein, J.H.12
Weissman, N.J.13
-
21
-
-
0036857350
-
A new noninvasive measurement system for wave intensity: Evaluation of carotid arterial wave intensity and reproducibility
-
DOI 10.1007/s003800200037
-
Niki K, Sugawara M, Chang D, Harada A, Okada T, Sakai R, Uchida K, Tanaka R, Mumford CE: A new noninvasive measurement system for wave intensity: evaluation of carotid arterial wave intensity and reproducibility. Heart Vessels 2002; 17: 12-21. (Pubitemid 35423059)
-
(2002)
Heart and Vessels
, vol.17
, Issue.1
, pp. 12-21
-
-
Niki, K.1
Sugawara, M.2
Chang, D.3
Harada, A.4
Okada, T.5
Sakai, R.6
Uchida, K.7
Tanaka, R.8
Mumford, C.E.9
-
22
-
-
0025730623
-
Elevated endogenous digitalislike substance in hypertensive diabetic patients with a family history of hypertension
-
Okamoto S, Ikeda M, Morise T, Miyamori I, Takeda R: Elevated endogenous digitalislike substance in hypertensive diabetic patients with a family history of hypertension. J Endocrinol Invest 1991; 14: 357-360.
-
(1991)
J Endocrinol Invest
, vol.14
, pp. 357-360
-
-
Okamoto, S.1
Ikeda, M.2
Morise, T.3
Miyamori, I.4
Takeda, R.5
-
23
-
-
33847262462
-
Involvement of endogenous ouabain-like compound in cardiac hypertrophic process in vivo
-
Skoumal R, Szokodi I, Aro J, Földes G, Göoz M, Seres L, Sármán B, Lakó-Futó Z, Papp L, Vuolteenaho O, Leppäluoto J, DeChâtel R, Ruskoaho H, Tóth M: Involvement of endogenous ouabain-like compound in cardiac hypertrophic process in vivo. Life Sci 2007; 80: 1303-1310.
-
(2007)
Life Sci
, vol.80
, pp. 1303-1310
-
-
Skoumal, R.1
Szokodi, I.2
Aro, J.3
Földes, G.4
Göoz, M.5
Seres, L.6
Sármán, B.7
Lakó-Futó, Z.8
Papp, L.9
Vuolteenaho, O.10
Leppäluoto, J.11
Dechâtel, R.12
Ruskoaho, H.13
Tóth, M.14
-
24
-
-
19344376290
-
Urinary-peptide excretion by patients with and volunteers without diabetes
-
DOI 10.1016/j.lab.2004.11.021, PII S0022214305000405
-
Strong KJ, Osicka TM, Comper WD: Urinary- peptide excretion by patients with and volunteers without diabetes. J Lab Clin Med 2005; 145: 239-246. (Pubitemid 40719930)
-
(2005)
Journal of Laboratory and Clinical Medicine
, vol.145
, Issue.5
, pp. 239-246
-
-
Strong, K.J.1
Osicka, T.M.2
Comper, W.D.3
-
25
-
-
60749134927
-
Molecular heterogeneity of urinary albumin in glomerulonephritis: Comparison of cardiovascular disease with albuminuria
-
Nakayama A, Sakatsume M, Kasama T, Kawara T, Gejyo F, Isobe M, Sato K, Shiba K: Molecular heterogeneity of urinary albumin in glomerulonephritis: comparison of cardiovascular disease with albuminuria. Clin Chim Acta 2009; 402: 94-101.
-
(2009)
Clin Chim Acta
, vol.402
, pp. 94-101
-
-
Nakayama, A.1
Sakatsume, M.2
Kasama, T.3
Kawara, T.4
Gejyo, F.5
Isobe, M.6
Sato, K.7
Shiba, K.8
-
26
-
-
2442690211
-
Degradation of albumin by the renal proximal tubule-cells and the subsequent fate of its fragments
-
DOI 10.1111/j.1523-1755.2004.00633.x
-
Gudehithlu KP, Pegoraro AA, Dunea G, Arruda JA, Singh AK: Degradation of albumin by the renal proximal tubule cells and the subsequent fate of its fragments. Kidney Int 2004; 65: 2113-2122. 27 Markó L, Molnár GA, Wagner Z, Böddi K, Koszegi T, Szabó Z, Matus Z, Szijá rtó I, Mérei A, Nagy G, Wittmann I: Measurement of the modification and interference rate of urinary albumin detected by size-exclusion HPLC. Physiol Meas 2009; 30: 1137-1150. (Pubitemid 38669997)
-
(2004)
Kidney International
, vol.65
, Issue.6
, pp. 2113-2122
-
-
Gudehithlu, K.P.1
Pegoraro, A.A.2
Dunea, G.3
Arruda, J.A.L.4
Singh, A.K.5
-
27
-
-
70350463842
-
Measurement of the modification and interference rate of urinary albumin detected by size-exclusion HPLC
-
Markó L, Molnár GA, Wagner Z, Böddi K, Koszegi T, Szabó Z, Matus Z, Szijártó I, Mérei A, Nagy G, Wittmann I: Measurement of the modification and interference rate of urinary albumin detected by size-exclusion HPLC. Physiol Meas 2009; 30: 1137-1150
-
(2009)
Physiol Meas
, vol.30
, pp. 1137-1150
-
-
Markó, L.1
Molnár, G.A.2
Wagner, Z.3
Böddi, K.4
Koszegi, T.5
Szabó, Z.6
Matus, Z.7
Szijártó, I.8
Mérei, A.9
Nagy Wittmann G, I.10
|